L

Levi A. Garraway

Broad Institute

ORCID: 0000-0003-3739-0471

Publishes on Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways, Computational Drug Discovery Methods. 1k papers and 150.3k citations.

PubIndex Score98Top 2%How it's scored

🌟#5 Current Senior Leader in Melanoma and MAPK Pathways

1kPublications

150.3kTotal Citations

#5in Melanoma and MAPK Pathways

First publication: 1991First senior author: 2006

Cancer Genomics and Diagnostics Melanoma and MAPK Pathways Computational Drug Discovery Methods Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

Top publicationsby citations

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Itay Tirosh, Levi A. Garraway, Benjamin Izar et al.|Science|2016

Cited by 5.3k

Discovery and saturation analysis of cancer genes across 21 tumour types

Michael S. Lawrence, Gad Getz, Petar Stojanov et al.|Nature|2014

Cited by 3.2k

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Levi A. Garraway, William R. Sellers, Hans R. Widlund et al.|Nature|2005

Cited by 1.5k

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon, Charles H. Yoon, Parin Shah et al.|Cell|2018

Cited by 1.5k

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Cory M. Johannessen, Levi A. Garraway, Jesse S. Boehm et al.|Nature|2010

Cited by 1.4k